Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mangafodipir trisodium

The trisodium salt of mangafodipir with potential antioxidant and chemoprotective activities. Consisting of manganese (II) ions chelated to fodipir… Expand
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

MANGAFODIPIR

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Hepatobiliary-specific contrast agents are one of several classes of contrast agents available for magnetic resonance (MR… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2004
Review
2004
Manganese toxicity upon overexposure
Manganese (Mn) is a required element and a metabolic byproduct of the contrast agent mangafodipir trisodium (MnDPDP). The Mn… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
PURPOSE To compare biliary tract depiction in living potential liver donors at conventional magnetic resonance (MR), mangafodipir… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast‐enhanced magnetic resonance cholangiography
To determine the diagnostic performance of functional magnetic resonance cholangiography (fMRC) for the evaluation of anatomic… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
OBJECTIVE The purpose of this study was to compare mangafodipir trisodium-enhanced MR imaging performed with a phased array coil… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
PURPOSE To evaluate whether mangafodipir trisodium (Mn-DPDP)-enhanced magnetic resonance (MR) imaging surpasses dual-phase spiral… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging
Abstract. The aim of this work was to study the ability of mangafodipir trisodium (Mn-DPDP)-enhanced MR imaging in… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
1999
1999
Mangafodipir trisodium: Effects on T2‐ and T1‐weighted MR cholangiography
The purpose of this study was to determine the effects of mangafodipir trisodium on heavily T2‐weighted magnetic resonance… Expand
Is this relevant?
1998
1998
Inflammatory pseudotumor of the liver: MRI with mangafodipir trisodium.
Inflammatory pseudotumor of the liver is a rare benign mass that is often misdiagnosed as hepatocellular carcinoma at… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
PURPOSE To determine the efficacy of manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) at… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE